Literature DB >> 30780137

Combining many-objective radiomics and 3D convolutional neural network through evidential reasoning to predict lymph node metastasis in head and neck cancer.

Liyuan Chen1, Zhiguo Zhou, David Sher, Qiongwen Zhang, Jennifer Shah, Nhat-Long Pham, Steve Jiang, Jing Wang.   

Abstract

Lymph node metastasis (LNM) is a significant prognostic factor in patients with head and neck cancer, and the ability to predict it accurately is essential to optimizing treatment. Positron emission tomography (PET) and computed tomography (CT) imaging are routinely used to identify LNM. Although large or highly active lymph nodes (LNs) have a high probability of being positive, identifying small or less reactive LNs is challenging. The accuracy of LNM identification strongly depends on the physician's experience, so an automatic prediction model for LNM based on CT and PET images is warranted to assist LMN identification across care providers and facilities. Radiomics and deep learning are the two promising imaging-based strategies for node malignancy prediction. Radiomics models are built based on handcrafted features, while deep learning learns the features automatically. To build a more reliable model, we proposed a hybrid predictive model that takes advantages of both radiomics and deep learning based strategies. We designed a new many-objective radiomics (MaO-radiomics) model and a 3D convolutional neural network (3D-CNN) that fully utilizes spatial contextual information, and we fused their outputs through an evidential reasoning (ER) approach. We evaluated the performance of the hybrid method for classifying normal, suspicious and involved LNs. The hybrid method achieves an accuracy (ACC) of 0.88 while XmasNet and Radiomics methods achieve 0.81 and 0.75, respectively. The hybrid method provides a more accurate way for predicting LNM using PET and CT.

Entities:  

Mesh:

Year:  2019        PMID: 30780137      PMCID: PMC7178778          DOI: 10.1088/1361-6560/ab083a

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

Review 1.  Dissecting the metastatic cascade.

Authors:  Klaus Pantel; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 2.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 3.  Radiomics: the bridge between medical imaging and personalized medicine.

Authors:  Philippe Lambin; Ralph T H Leijenaar; Timo M Deist; Jurgen Peerlings; Evelyn E C de Jong; Janita van Timmeren; Sebastian Sanduleanu; Ruben T H M Larue; Aniek J G Even; Arthur Jochems; Yvonka van Wijk; Henry Woodruff; Johan van Soest; Tim Lustberg; Erik Roelofs; Wouter van Elmpt; Andre Dekker; Felix M Mottaghy; Joachim E Wildberger; Sean Walsh
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

4.  Urinary bladder cancer staging in CT urography using machine learning.

Authors:  Sankeerth S Garapati; Lubomir Hadjiiski; Kenny H Cha; Heang-Ping Chan; Elaine M Caoili; Richard H Cohan; Alon Weizer; Ajjai Alva; Chintana Paramagul; Jun Wei; Chuan Zhou
Journal:  Med Phys       Date:  2017-09-05       Impact factor: 4.071

5.  Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.

Authors:  Brian A Moore; Randal S Weber; Victor Prieto; Adel El-Naggar; F Christopher Holsinger; Xian Zhou; J Jack Lee; Scott Lippman; Gary L Clayman
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

6.  Radiomic phenotype features predict pathological response in non-small cell lung cancer.

Authors:  Thibaud P Coroller; Vishesh Agrawal; Vivek Narayan; Ying Hou; Patrick Grossmann; Stephanie W Lee; Raymond H Mak; Hugo J W L Aerts
Journal:  Radiother Oncol       Date:  2016-04-13       Impact factor: 6.280

7.  A deep feature fusion methodology for breast cancer diagnosis demonstrated on three imaging modality datasets.

Authors:  Natalia Antropova; Benjamin Q Huynh; Maryellen L Giger
Journal:  Med Phys       Date:  2017-08-12       Impact factor: 4.071

8.  Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.

Authors:  Xi Chen; Zhiguo Zhou; Raquibul Hannan; Kimberly Thomas; Ivan Pedrosa; Payal Kapur; James Brugarolas; Xuanqin Mou; Jing Wang
Journal:  Phys Med Biol       Date:  2018-10-24       Impact factor: 3.609

9.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

10.  CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.

Authors:  Dae Young Yoon; Hee Sung Hwang; Suk Ki Chang; Young-Soo Rho; Hwoe Young Ahn; Jin Hwan Kim; In Jae Lee
Journal:  Eur Radiol       Date:  2008-10-09       Impact factor: 5.315

View more
  17 in total

1.  A collection input based support tensor machine for lesion malignancy classification in digital breast tomosynthesis.

Authors:  Benjuan Yang; Yingjiang Wu; Zhiguo Zhou; Shulong Li; Genggeng Qin; Liyuan Chen; Jing Wang
Journal:  Phys Med Biol       Date:  2019-12-05       Impact factor: 3.609

2.  A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.

Authors:  Kuo Men; Huaizhi Geng; Haoyu Zhong; Yong Fan; Alexander Lin; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

3.  Toward predicting the evolution of lung tumors during radiotherapy observed on a longitudinal MR imaging study via a deep learning algorithm.

Authors:  Chuang Wang; Andreas Rimner; Yu-Chi Hu; Neelam Tyagi; Jue Jiang; Ellen Yorke; Sadegh Riyahi; Gig Mageras; Joseph O Deasy; Pengpeng Zhang
Journal:  Med Phys       Date:  2019-09-06       Impact factor: 4.071

4.  Radiomics analysis of [18F]-fluoro-2-deoxyglucose positron emission tomography for the prediction of cervical lymph node metastasis in tongue squamous cell carcinoma.

Authors:  Takaharu Kudoh; Akihiro Haga; Keiko Kudoh; Akira Takahashi; Motoharu Sasaki; Yasusei Kudo; Hitoshi Ikushima; Youji Miyamoto
Journal:  Oral Radiol       Date:  2022-03-07       Impact factor: 1.852

Review 5.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

Review 6.  An introduction to deep learning in medical physics: advantages, potential, and challenges.

Authors:  Chenyang Shen; Dan Nguyen; Zhiguo Zhou; Steve B Jiang; Bin Dong; Xun Jia
Journal:  Phys Med Biol       Date:  2020-03-03       Impact factor: 3.609

Review 7.  Artificial intelligence in molecular imaging.

Authors:  Edward H Herskovits
Journal:  Ann Transl Med       Date:  2021-05

8.  Segmentation of metastatic cervical lymph nodes from CT images of oral cancers using deep-learning technology.

Authors:  Yoshiko Ariji; Yoshitaka Kise; Motoki Fukuda; Chiaki Kuwada; Eiichiro Ariji
Journal:  Dentomaxillofac Radiol       Date:  2022-02-18       Impact factor: 3.525

9.  Computer-aided diagnosis of masses in breast computed tomography imaging: deep learning model with combined handcrafted and convolutional radiomic features.

Authors:  Marco Caballo; Andrew M Hernandez; Su Hyun Lyu; Jonas Teuwen; Ritse M Mann; Bram van Ginneken; John M Boone; Ioannis Sechopoulos
Journal:  J Med Imaging (Bellingham)       Date:  2021-03-29

Review 10.  Applications of artificial intelligence in oncologic 18F-FDG PET/CT imaging: a systematic review.

Authors:  Mohammad S Sadaghiani; Steven P Rowe; Sara Sheikhbahaei
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.